Areas of Focus
- Regulation and Pathogenesis of Immune Aging
Work Experience
- 2015-06~Present - Shanghai Institute of Life Sciences, Chinese Academy of Sciences - Researcher
- 2010-07~2015-05 - MD Anderson Cancer Center - Postdoctoral fellow
- 2007-09~2010-06 - Shanghai Institute of Life Sciences, Chinese Academy of Sciences - PhD
- 2006-07~2007-07 - Shanghai Information Center for Life Sciences, Chinese Academy of Sciences - Editor
- 2003-09~2006-06 - East China University of Science and Technology - Master's
- 1999-09~2003-06 - Hubei University - Bachelor's
Academic Background & Achievements
- 2007-09--2010-06 PhD: Shanghai Institute of Life Sciences, Chinese Academy of Sciences
- 2003-09--2006-06 Master's: East China University of Science and Technology
- 1999-09--2003-06 Bachelor's: Hubei University
Publications
- Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence, Xiao Yichuan, 2024
- Goliath induces inflammation in obese mice by linking fatty acid β-oxidation to glycolysis, Xiao Yichuan, 2023
- Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activation, Xiao Yichuan, 2022
- The ubiquitin ligase Peli1 inhibits ICOS and thereby Tfh-mediated immunity, Xiao Yichuan, 2021
- BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy, Xiao Yichuan, 2021
- Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation, Xiao Yichuan, 2021
- TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination, Xiao Yichuan, 2020
- Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation, Xiao Yichuan, 2020
Awards
- Harold C and Mary L. Daily Fellowship (2015): Special Award
- Harold C and Mary L. Daily Fellowship (2013): Special Award
